MedPeer, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
No of Months
12
12
12
12
12
12
Profit Before Tax
2,371.00
1,046.00
1,113.00
1,812.00
1,130.00
557.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
488.00
-821.00
198.00
-104.00
-181.00
-81.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1,890.00
600.00
853.00
1,361.00
930.00
374.00
Cash Flow from Investing Activities
1,266.00
-5,011.00
-422.00
-340.00
-469.00
-138.00
Cash Flow from Financing Activities
-1,269.00
3,666.00
7.00
-20.00
1,110.00
1,069.00
Net Cash Inflow / Outflow
1,886.00
-745.00
437.00
1,000.00
1,571.00
1,305.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of MedPeer, Inc.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
2371.502
2171
200.00
9.24%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
488.091
976
-488.00
-49.99%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
1890.649
2035
-145.00
-7.09%
Cash Flow from Investing Activities
1266.124
-237
1,503.00
634.23%
Cash Flow from Financing Activities
-1269.931
-507
-762.00
-150.48%
Net Cash Inflow / Outflow
1886.842
1297
589.00
45.48%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
6
-6.00
-100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Sep'24
YoY Growth in year ended Sep 2024 is 215.07% vs -29.67% in Sep 2023
Sep'24
Sep'23
Change(%)
Cash Flow from Operating Activities
1,890.65
600.07
215.07%






